163 related articles for article (PubMed ID: 19806092)
1. Are split bowel preparation regimens practical for morning colonoscopies? Implications of the new american college of gastroenterology colon cancer screening guidelines for real-world clinical practice.
Lin OS; Schembre DB
Am J Gastroenterol; 2009 Oct; 104(10):2627-8; author reply 2628-9. PubMed ID: 19806092
[No Abstract] [Full Text] [Related]
2. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008.
Dominic OG; McGarrity T; Dignan M; Lengerich EJ
Am J Gastroenterol; 2009 Oct; 104(10):2626-7; author reply 2628-9. PubMed ID: 19806090
[No Abstract] [Full Text] [Related]
3. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].
Rex DK; Johnson DA; Anderson JC; Schoenfeld PS; Burke CA; Inadomi JM;
Am J Gastroenterol; 2009 Mar; 104(3):739-50. PubMed ID: 19240699
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer guidance is self-serving.
Meyer GW
Am J Gastroenterol; 2009 Oct; 104(10):2626; author reply 2628-9. PubMed ID: 19806091
[No Abstract] [Full Text] [Related]
5. Bowel preparation and colonoscopy technique to detect non-polypoid colorectal neoplasms.
Kim HN; Raju GS
Gastrointest Endosc Clin N Am; 2010 Jul; 20(3):437-48. PubMed ID: 20656242
[TBL] [Abstract][Full Text] [Related]
6. Standards of care in diagnosis and testing for hereditary colon cancer.
Lynch PM
Fam Cancer; 2008; 7(1):65-72. PubMed ID: 17701450
[TBL] [Abstract][Full Text] [Related]
7. Bowel preparation for colonoscopy with magnesium sulphate and low-volume polyethylene glycol.
Tepeš B; Mlakar DN; Metličar T
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):616-20. PubMed ID: 24694759
[TBL] [Abstract][Full Text] [Related]
8. Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial.
Rodríguez de Miguel C; Serradesanferm A; López-Cerón M; Carballal S; Pozo A; Balaguer F; Cárdenas A; Fernández-Esparrach G; Ginés A; González-Suárez B; Moreira L; Ordás I; Ricart E; Sendino O; Vaquero EC; Ubré M; del Manzano S; Grau J; Llach J; Castells A; Pellisé M;
Gastroenterol Hepatol; 2015 Feb; 38(2):62-70. PubMed ID: 25458542
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of sodium phosphate tablets vs polyethylene glycol solution for colonoscopy bowel cleansing.
Jung YS; Lee CK; Kim HJ; Eun CS; Han DS; Park DI
World J Gastroenterol; 2014 Nov; 20(42):15845-51. PubMed ID: 25400471
[TBL] [Abstract][Full Text] [Related]
10. Effect of Coffee Added to a Polyethylene glycol plus Ascorbic acid Solution for Bowel Preparation prior to Colonoscopy.
Jung SW; Moh IH; Yoo H; Jang SI; Shin SR; Kim JB; Park SH; Lee MS
J Gastrointestin Liver Dis; 2016 Mar; 25(1):63-9. PubMed ID: 27014755
[TBL] [Abstract][Full Text] [Related]
11. Barriers against split-dose bowel preparation for colonoscopy.
Radaelli F; Paggi S; Repici A; Gullotti G; Cesaro P; Rotondano G; Cugia L; Trovato C; Spada C; Fuccio L; Occhipinti P; Pace F; Fabbri C; Buda A; Manes G; Feliciangeli G; Manno M; Barresi L; Anderloni A; Dulbecco P; Rogai F; Amato A; Senore C; Hassan C
Gut; 2017 Aug; 66(8):1428-1433. PubMed ID: 27196589
[TBL] [Abstract][Full Text] [Related]
12. A molecular rationale for the how, when and why of colorectal cancer screening.
Souza RF
Aliment Pharmacol Ther; 2001 Apr; 15(4):451-62. PubMed ID: 11284773
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal Adherence in Clinical Practice to Guidelines Recommendation to Screen for Lynch Syndrome.
Jain A; Shafer L; Rothenmund H; Kim CA; Samadder J; Gupta S; Singh H
Dig Dis Sci; 2019 Dec; 64(12):3489-3501. PubMed ID: 31187321
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of low-volume (2 L) versus single- (4 L) versus split-dose (2 L + 2 L) polyethylene glycol bowel preparation for colonoscopy: randomized clinical trial.
Téllez-Ávila FI; Murcio-Pérez E; Saúl A; Herrera-Gómez S; Valdovinos-Andraca F; Acosta-Nava V; Barreto R; Elizondo-Rivera J
Dig Endosc; 2014 Nov; 26(6):731-6. PubMed ID: 24645966
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal cancer.
Kronborg O
Scand J Surg; 2003; 92(1):20-4. PubMed ID: 12705547
[No Abstract] [Full Text] [Related]
16. Can the identification of high risk groups increase the effectiveness of colon cancer screening programmes?
Vasen HF
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S41-2. PubMed ID: 18368642
[No Abstract] [Full Text] [Related]
17. Time for individualized colonoscopy bowel-prep regimens? A randomized controlled trial comparing sodium picosulphate and magnesium citrate versus 4-liter split-dose polyethylene glycol.
Voiosu T; Ratiu I; Voiosu A; Iordache T; Schipor A; Baicus C; Sporea I; Voiosu R
J Gastrointestin Liver Dis; 2013 Jun; 22(2):129-34. PubMed ID: 23799210
[TBL] [Abstract][Full Text] [Related]
18. [Colorectal cancer screening].
Kronborg O
Ugeskr Laeger; 2002 Jan; 164(2):153-5. PubMed ID: 11831075
[No Abstract] [Full Text] [Related]
19. Management of high-risk colonoscopy patients.
Bresalier RS
Gastrointest Endosc Clin N Am; 2010 Oct; 20(4):629-40. PubMed ID: 20889068
[TBL] [Abstract][Full Text] [Related]
20. Caring for patients at risk for hereditary colorectal cancer.
Greco K
Oncology (Williston Park); 2007 Feb; 21(2 Suppl Nurse Ed):29-38; discussion 39. PubMed ID: 17476735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
